Delivery Order V797P5025B-VA24115J1423

Veterans Integrated Service Network 9 issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 18, 2026, for BREYANZI CAR T cell therapy for transplant under the Department of Veterans Affairs Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The order is firm fixed price with no set-aside designation. Place of performance is Lawrenceville, New Jersey, with an ultimate completion date of September 17, 2026. BREYANZI (lisocabtagene maraleucel) is a...

Veterans Integrated Service Network 15 issued a delivery order to Cardinal Health 414, LLC on May 1, 2026, for radiopharmaceuticals with a ceiling value of $106,851.51 under a firm fixed-price structure. The order covers the period May 1, 2026 through July 31, 2026. Place of performance is Dublin, OH. Cardinal Health 414 manufactures, tests, and distributes radiopharmaceuticals and medical isotopes to federal healthcare agencies, including technetium-99m, iodine-123, iodine-131, indium-111,...

This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of Xofigo (radium Ra-223 dichloride injection), a radiopharmaceutical treatment for prostate cancer, with an individual dose of 166.14 microcuries to be administered about every 4 weeks up to a total of 6 doses. The contract has a ceiling value of $75,105.29 and is a firm-fixed-price...

Veterans Integrated Service Network 22 issued a $181,385.65 delivery order to Bayer Healthcare Pharmaceuticals Inc. on April 1, 2026, for XOFIGO (radium-223 dichloride injection) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The FSS-61-IB is an $840 million multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs enabling delivery orders for pharmaceutical products across federal agencies. Place of performance is Dublin, OH. The order...

The Department of Veterans Affairs, Veterans Integrated Service Network 15, issued a BPA call to Advanced Accelerator Applications USA Inc. for PLUVICTO and LUTATHERA radiopharmaceutical products with a ceiling value of $1,140,421.68 on February 17, 2024, with ultimate completion on February 16, 2025. The call was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) on a firm fixed-price basis. Place of performance is New York, New York. PLUVICTO (lutetium Lu 177...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $2,789.25. This is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, and represents a non-set-aside competitive award. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...

Veterans Integrated Service Network 9 issued a delivery order to Cardinal Health 414, LLC on October 1, 2025, for Lymphoseek and F-18 FDG radiopharmaceuticals with a ceiling value of $103,028.50. Place of performance is Dublin, OH. The order is firm fixed price with an ultimate completion date of September 30, 2026. Cardinal Health 414 manufactures and distributes radiopharmaceuticals and medical isotopes to federal healthcare agencies, including technetium-99m, iodine-123, iodine-131,...

The Defense Logistics Agency awarded a delivery order valued at $3,919.24 to AmerisourceBergen Drug Corp for the supply of ZOLADEX 10.8 mg implant syringes under a firm fixed price arrangement. The contract was competitively awarded without set-aside designation and is scheduled for completion by January 5, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...

<p>The Defense Logistics Agency issued a $6,875.91 delivery order to Amerisourcebergen Drug Corp on April 8, 2026, for ZIRABEV 400 mg/16 ml vials under firm fixed-price terms. The order is placed against the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is April 9, 2026. No set-aside was used.</p>

Defense Logistics Agency awarded a $4,229.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ZOLADEX 10.8 MG IMPLANT SYRNS. The delivery order was awarded on October 16, 2023 under the corporate vendor's blanket purchase agreement and has a period of performance through November 6, 2023. The delivery order utilizes no set-aside designation and will be fulfilled out of the vendor's location in Conshohocken, Pennsylvania to support the Defense Logistics Agency's medical...